Lu-177-Vipivotide tetraxetan (Pluvicto™)
177Lu-Vipivotide tetratexan (177Lu-PSMA-617) is a 177Lu labeled peptide developed [...]
177Lu-Vipivotide tetratexan (177Lu-PSMA-617) is a 177Lu labeled peptide developed [...]
225Ac-PSMA-617 is the next generation of prostate cancer treatment following [...]